BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
    • Interviews
  • News
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Exosomes
  • CAR-T
  • Cord Blood
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » Cord Blood

Cord Blood

Because cord blood present within a newborn’s umbilical is rich with stem cells, it can be collected and stored for future medical use.

The Best Cord Blood Bank of 2022: Which One Should You Choose?

August 7, 2022 By Cade Hildreth (CEO) Leave a Comment

Best cord blood bank 2022

After choosing a name for your newborn, the next decision you’ll need to make is whether or not you want to save their cord blood. It’s a choice you will need to make swiftly, as the window to successfully store your child’s cord blood and cord tissue is a relatively small one.

While there is a lot of information available for expecting parents, sifting through all the options to find the best cord blood bank can be overwhelming, especially if you’re not exactly familiar with all the terms and technology. [Read more…]

Filed Under: Cord Blood Tagged With: cord blood

Placental Stem Cells – Interview with Dr. Ornella Parolini of IPLASS

August 6, 2022 By Cade Hildreth (CEO) 3 Comments

In this interview with Dr. Ornella Parolini, Director of the E. Menni Research Center in Italy, we discussed her pioneering research on human placental stem cells. Her research is focused on the immunomodulatory and anti-inflammatory properties of amniotic and chorionic membrane cells. She is also President of the International Placenta Stem Cell Society (IPLASS), making her a globally recognized expert.

In addition to Dr. Robert Harari who holds a wide range of placental stem cell patents, Dr. Parolini is one of the world’s leading experts on placental stem cells and their therapeutic applications.

In this article:

  • Definition of Placental Stem Cells
  • Interview with Placental Stem Cell Expert, Dr. Parolini
  • Placental Stem Cell Advantages
  • International Placental Stem Cell Society
  • Clinical Applications of Placental Stem Cells

[Read more…]

Filed Under: Cord Blood, Interviews Tagged With: cord blood, hematopoietic, perinatal stem cells, placental stem cells, Q&A

PeptiGrowth Inc. is Launching A Novel Synthetic Peptide BMP4,7 inhibitor (Noggin-like peptide)

July 26, 2022 By Cade Hildreth (CEO) Leave a Comment

PeptiGrowth Graphs

July 26, 2022, Tokyo, Japan – PeptiGrowth Inc. (Headquarters: Chiyoda-ku, Tokyo, President: Jiro Sugimoto) has successfully developed a novel synthetic peptide “BMP4,7 inhibitor (Noggin-like peptide)” which binds to several Bone Morphogenetic Proteins (BMPs) to inhibit its activity like Noggin. It will be marketing this product from July, 2022. [Read more…]

Filed Under: Cord Blood

How is Public Cord Blood Banking Funded?

July 16, 2022 By Cade Hildreth (CEO) Leave a Comment

How Public Cord Blood Banking is Funded

Currently, it costs a public bank approximately USD $2,000 to collect, test, and process a unit of cord blood for storage. In order to accept donations at no cost, public banks require income to support themselves. This income can come from federal funding, the profit margin of private banking, or from selling donated cord blood units for research. Alternatively, it can come from a combination of the above.

[Read more…]

Filed Under: Cord Blood Tagged With: cord blood, cord blood funding, funding, public cord blood bank funding, public cord blood banking, public cord blood banking market

Cord Blood Industry Consolidation Escalates in 2022

June 11, 2022 By Cade Hildreth (CEO) 2 Comments

cord blood industry

The global cord blood industry experienced strong growth from the early 1990’s through the late 2000’s, during which time more than 450 cord blood banking companies emerged worldwide. Approximately half of those companies owned their own labs, while the others were marketing entities or sub-contractors of storage space.

Starting about ten years ago, the market suddenly changed course. It entered a period of aggressive consolidation, cutting the global number of cord blood banks by approximately half.

Over the past decade, the cord blood industry has witnessed substantial consolidation, particularly within the United States, Europe, Asia, and Latin America. [Read more…]

Filed Under: Cord Blood, HSCs Tagged With: cord blood, merger, news, trends

  • 1
  • 2
  • 3
  • …
  • 58
  • Next Page »

Nanocellect

Marathon Products

Kimera Society

Let’s Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
  • Instagram

Cart

Top Rated Products

  • Job Posting on BioInformant <Job Posting on BioInformant.com - Your Perfect Hire Is In Our Audience $297
  • U.S. Cord Blood Banking Survey <Cord Blood Banking Survey of U.S. Parents [2017] $197
  • Exosome Companies 2020 <Global Database of Exosome Companies $149 $97

Featured Posts

iPSC derived cell therapeutics

The Pipeline for iPSC-Derived Cell Therapeutics in 2022

Stem cell companies

List of Stem Cell Companies Worldwide (2022)

Feature | Exosome Companies | Exosome Companies | Tiny Exosomes, Enormous Potential

List of Exosome Companies: Tiny Packages, Enormous Potential

My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2022 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: [email protected] | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.